Iovate Health Sciences International Inc. and Iovate Health Sciences International Inc.

CourtUnited States Bankruptcy Court, S.D. New York
DecidedSeptember 12, 2025
Docket25-11958
StatusUnknown

This text of Iovate Health Sciences International Inc. and Iovate Health Sciences International Inc. (Iovate Health Sciences International Inc. and Iovate Health Sciences International Inc.) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Iovate Health Sciences International Inc. and Iovate Health Sciences International Inc., (N.Y. 2025).

Opinion

UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT OF NEW YORK -----------------------------------------------------------------------x In re: FOR PUBLICATION

IOVATE HEALTH SCIENCES Chapter 15 INTERNATIONAL INC., et al., Case No. 25-11958 (MG)

Debtors in a Foreign Proceeding. -----------------------------------------------------------------------x

MEMORANDUM OPINION GRANTING MOTION FOR PROVISIONAL RELIEF

A P P E A R A N C E S:

PACHULSKI STANG ZIEHL & JONES LLP Attorneys for Foreign Representative 1700 Broadway, 36th Fl. New York, New York 10019 By: Steven W. Golden, Esq. Jeffrey M. Dine, Esq. Mary F. Caloway, Esq. Victoria A. Newmark, Esq.

MARTIN GLENN CHIEF UNITED STATES BANKRUPTCY JUDGE

The Court has already entered an order (ECF Doc. # 20) granting the motion (“Motion,” ECF Doc. # 7) for provisional relief brought by Iovate Health Sciences International Inc. (“Iovate International”), in its capacity as the authorized foreign representative (the “Foreign Representative”) of itself, Iovate Health Sciences USA Inc. (“Iovate USA”), and Northern Innovations Holding Corp. (“Northern Innovations”) (collectively, the “Debtors”). The Court now writes separately to explain its reasoning in granting provisional relief. This is the third recent Chapter 15 case before this Court in recent months which has involved Canadian entities in a Canadian insolvency proceeding where one of the entities in the debtor group was an American corporation and the Court determined that COMI of the American companies was in Canada. See In re Giftcraft Ltd., No. 25-11030 (MG), 2025 WL 1583480, at *1 (Bankr. S.D.N.Y. June 4, 2025); Oak and Fort and Affiliated Entities, Case No. 25-11282, ECF Doc. # 13. The Court writes to address a recurrent issue: when the presumption that an entity’s COMI is in the jurisdiction of its registered office can be overcome.

In support of its Motion, counsel for the (proposed) Foreign Representative submitted two declarations by Wesley Parris, CEO of the proposed foreign representative, in support of the motions for provisional and final relief (“Parris Decl. 1,” ECF Doc. # 5, and “Parris Decl. 2,” ECF Doc. # 16); and a declaration by Harvey Chaiton, a partner at Chaitons LLP, concerning Canadian insolvency law (“Chaiton Decl.,” ECF Doc. # 6). All declarations were admitted into evidence during the September 10, 2025 hearing on the Motion. The Foreign Representative also filed a recognition motion (“Recognition Motion,” ECF Doc. # 4) seeking, among other things, recognition of the Canadian Proceeding (defined infra) as the foreign main proceeding (or, in the alternative, the foreign nonmain proceeding) of each of the Debtors. No one challenged the Motion for provisional relief.

For the following reasons, the Court has found that the Foreign Representative has shown that the foreign (Canadian) insolvency proceeding is likely to be found to be the foreign main proceeding for each of the Debtors; that failing to grant the provisional relief would have resulted in imminent irreparable harm to the Debtors; that the balance of harms tipped in favor of the Debtors; and that the public interest weighed in favor of granting the relief. I. BACKGROUND A. Company Background The Debtors, together with their non-debtor affiliates (together, “Iovate Group”), comprise a health and wellness business based in Oakville, Ontario, Canada, specializing in active nutrition and weight management products, specifically supplements and vitamins. (Parris Decl. 1 ¶ 4.) Initially headquartered in Mississauga, Ontario, the Iovate Group began as a direct- to-consumer mail order business, and eventually expanded; now, its products are distributed in over 90 countries. (Id. ¶ 5.) The Iovate Group manufactures and distributes its products through

third-party co-manufacturers and a network of domestic and international distribution partners. (Id. ¶ 6.) Its products are shipped from facilities in Canada, the United States, Belgium, and Australia, and are sold through retail, online, and distributor channels globally. (Id.) As of the date of filing of their Chapter 15 cases (September 9, 2025), Iovate International leases its corporate head office in Oakville, Ontario, Canada (the “Oakville Headquarters”). (Id. ¶ 7.) None of the Debtors lease any other real property. (Id.) Parris and the Debtors’ other management work out of the Oakville Headquarters. (Id.) Iovate International employs approximately 165 people in Canada and two people in the United Kingdom. (Id.) (Parris also states that all of Iovate International’s employees are located in Ontario. (Id.)) Most of Iovate Group’s operations are conducted through Iovate International.

(Id. ¶ 8.) Iovate Group’s inventory and raw materials are owned by Iovate International (as is most of Iovate Group’s cash, non-United States accounts receivables, and other assets other than intellectual property) and its intellectual property is owned by Northern Innovations. (Id.) Iovate International is an Ontario corporation governed by the Ontario Business Corporations Act and its registered office is located in Oakville, Ontario, Canada. (Id. ¶ 9.) Iovate USA employs approximately 11 people in the United States, most of whom are salespeople. (Id. ¶ 7.) Iovate USA, generally speaking, is responsible for overseeing warehousing and third-party logistics for Iovate Group’s non-Canadian customers and maintains Iovate Group’s relationships with United States-based customers. (Id. ¶ 8.) Iovate USA’s principal asset is accounts receivable from United States-based customers, which are deposited into New York-based bank accounts with HSBC USA but swept daily into Iovate International’s Toronto-based concentration account with Royal Bank of Canada (“RBC”). (Id.) Iovate USA is a Delaware limited liability company with its registered office in Wilmington, Delaware. (Id. ¶

9.) Northern Innovations does not have any employees. (Id.) It is an Ontario corporation governed by the Ontario Business Corporations Act and its registered office is in Oakville, Ontario, Canada. (Id. ¶ 9.) All of the Debtors are headquartered in Canada at the Oakville Headquarters. (Id.) The Debtors’ officers and senior management are all located in either Canada or China. (Id. ¶ 11.) Iovate International centrally manages all corporate activities of the Iovate Group from the Oakville Headquarters outside of Toronto. (Id. ¶ 10.) Iovate International’s CEO, Parris, is primarily responsible for the direction of the Debtors’ corporate, management, legal, investment, and strategic functions, all of which he manages from the Oakville Headquarters. (Id.) The

Debtors’ operations are highly integrated and share management and headquarters in Oakville, Ontario, Canada. (Id. ¶ 12.) All accounting, finance, and human resource functions for the Debtors are centralized and managed from the head office in Oakville, where payroll is also processed for all Canadian and U.S. operations.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Doctor's Associates, Inc. v. Emily Distajo
107 F.3d 126 (Second Circuit, 1997)
Morning Mist Holdings Ltd. v. Krys
714 F.3d 127 (Second Circuit, 2013)
In Re: RCS Capital Development v.
728 F.3d 301 (Third Circuit, 2013)
Faiveley Transport Malmo AB v. Wabtec Corp.
559 F.3d 110 (Second Circuit, 2009)
In Re Global Ocean Carriers Ltd.
251 B.R. 31 (D. Delaware, 2000)
In Re SPhinX, Ltd.
351 B.R. 103 (S.D. New York, 2006)
In Re Yukos Oil Co.
321 B.R. 396 (S.D. Texas, 2005)
In Re Betcorp Ltd.
400 B.R. 266 (D. Nevada, 2009)
In Re Lines
81 B.R. 267 (S.D. New York, 1988)
In Re Cenargo International, PLC
294 B.R. 571 (S.D. New York, 2003)
In Re Petition of Garcia Avila
296 B.R. 95 (S.D. New York, 2003)
In Re Abc Learning Centres Ltd.
445 B.R. 318 (D. Delaware, 2011)
Drawbridge Special Opportunities Fund LP v. Barnet
737 F.3d 238 (Second Circuit, 2013)
In re Millard
501 B.R. 644 (S.D. New York, 2013)
In re Octaviar Administration Pty Ltd.
511 B.R. 361 (S.D. New York, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
Iovate Health Sciences International Inc. and Iovate Health Sciences International Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/iovate-health-sciences-international-inc-and-iovate-health-sciences-nysb-2025.